Bildkälla: Stockfoto

Cantargia: Nadunolimab Soon Ready for Leukaemia Trial - Redeye

Cantargia today reported the preparations for the clinical trial of nadunolimab in leukaemia is going according to plan. The trial is scheduled to commence this summer.

Cantargia today reported the preparations for the clinical trial of nadunolimab in leukaemia is going according to plan. The trial is scheduled to commence this summer.
Börsvärldens nyhetsbrev
ANNONSER